RF Technologies
OVERVIEW
PIPELINEREPAIRCLAMP.COM TRAFFIC
Date Range
Date Range
Date Range
PIPELINEREPAIRCLAMP.COM HISTORY
SPAN
LINKS TO WEBSITE
WHAT DOES PIPELINEREPAIRCLAMP.COM LOOK LIKE?
CONTACTS
RF Technologies Sdn Bhd
Roslee Sikin
96-1, 1st Floor, Jalan Puteri 5/1, Bandar Puteri
Puchong, Selangor, 47100
MY
Interplay Systems Sdn Bhd
Patrick Lan
96-1, 1st Floor, Jalan Puteri 5/1, Bandar Puteri
Puchong, Selangor, 47100
MY
PIPELINEREPAIRCLAMP.COM SERVER
NAME SERVERS
SERVER SOFTWARE
We identified that this website is employing the Apache server.HTML TITLE
RF TechnologiesDESCRIPTION
Joomla! - the dynamic portal engine and content management systemPARSED CONTENT
The website pipelinerepairclamp.com has the following on the web page, "Pipeline Double Block Bleed Valve." I analyzed that the website also said " Instrument Double Block Bleed Valve." They also stated " RF TECHNOLOGIES GROUP OF COMPANIES. RF Technologies Group of companies is a Pipeline repair clamp, pipeline connector, pipeline mechanical plug and valves manufacturer for oil and gas, power generation, nuclear plant and petrochemical industries. RF Technologies Group, Inc. , will maintain Pipeline Repair Clamp, Connectors, Mechanical Plugs and Double Block and Bleed Valve are 100 Made in USA." The meta header had joomla as the first search term. This keyword was followed by Joomla which isn't as urgent as joomla.ANALYZE OTHER WEBSITES
Application Of Technowrap 2k Read more. 47A Adebayo Doherty Road,.
HIV, TB, and HCV. Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development. Written by Mike Frick, Annette Gaudino, Mark Harrington, Tim Horn, Richard Jefferys, Jeremiah Johnson, Erica Lessem, Marcus Low, and Lindsay McKenna.
Van Alstyne, TX 75495. Diams; Areas of Operations. 169;2014 PIPELINE RESOURCES INC.
Generex Pipeline Review by Rich Steffens. And their wholly owned subsidiary Antigen Express. Wednesday, May 15, 2013. Booster inoculations of the AE37 peptide vaccine enhance immunological responses in a phase II study. DURs occur infrequently and without long-term sequelae. Pts at risk for developing DUR are identified early in the vaccine series using LR.
DNA, RNA and Cells. DNA, RNA and Cells. Arbutus and Roivant Launch Genevant Sciences with Industry-Leading Platform to Develop Broad Range of RNA Therapeutics for Genetic Diseases. GSK Signs Strategic Agreement to Transfer Rare Disease Gene Therapy Portfolio to Orchard Therapeutics.